These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 24988065

  • 1. Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease.
    Yilmaz MI, Siriopol D, Saglam M, Kurt YG, Unal HU, Eyileten T, Gok M, Cetinkaya H, Oguz Y, Sari S, Vural A, Mititiuc I, Covic A, Kanbay M.
    Kidney Int; 2014 Dec; 86(6):1213-20. PubMed ID: 24988065
    [Abstract] [Full Text] [Related]

  • 2. Endocan--the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease.
    Pawlak K, Mysliwiec M, Pawlak D.
    Clin Biochem; 2015 Apr; 48(6):425-30. PubMed ID: 25617664
    [Abstract] [Full Text] [Related]

  • 3. Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients.
    Kanbay M, Siriopol D, Saglam M, Kurt YG, Gok M, Cetinkaya H, Karaman M, Unal HU, Oguz Y, Sari S, Eyileten T, Goldsmith D, Vural A, Veisa G, Covic A, Yilmaz MI.
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1854-61. PubMed ID: 25057883
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation.
    Ozalper V, Kara M, Tanoglu A, Cetındaglı I, Ozturker C, Hancerlı Y, Hıra S, Kara K, Beyazıt Y, Yazgan Y.
    Clin Rheumatol; 2017 Sep; 36(9):2071-2077. PubMed ID: 28074304
    [Abstract] [Full Text] [Related]

  • 5. Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome.
    Bicer M, Guler A, Unal Kocabas G, Imamoglu C, Baloglu A, Bilgir O, Yuksel A, Bozkaya G, Calan M.
    Endocr Res; 2017 May; 42(2):145-153. PubMed ID: 27911121
    [Abstract] [Full Text] [Related]

  • 6. Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease.
    Balta I, Balta S, Demirkol S, Mikhailidis DP, Celik T, Akhan M, Kurt O, Kurt YG, Aydin I, Kilic S.
    Br J Dermatol; 2013 Nov; 169(5):1066-70. PubMed ID: 23889284
    [Abstract] [Full Text] [Related]

  • 7. Serum markers for asymptomatic atherosclerosis in Egyptian psoriatic patients: study controlled by Doppler estimation of carotid intima-media thickness.
    Sabry HH, Sabry JH, Daifalla AEH, Akl EM, Hamed AM, Torky AAA.
    Vasc Health Risk Manag; 2018 Nov; 14():145-152. PubMed ID: 30022835
    [Abstract] [Full Text] [Related]

  • 8. Serum endocan as a predictive biomarker of cardiovascular risk in erectile dysfunction patients.
    Elkamshoushi AAM, Hassan EM, El Abd AM, Hassan SZ, Maher AA.
    Andrologia; 2018 Dec; 50(10):e13113. PubMed ID: 30039584
    [Abstract] [Full Text] [Related]

  • 9. Elevated endocan levels and its association with clinical severity in Stevens-Johnson Syndrome and toxic epidermal necrolysis.
    Syed D, Iqbal O, Mosier M, Mitchell R, Hoppensteadt D, Bouchard C, Fareed J, Gamelli R.
    Int Angiol; 2015 Oct; 34(5):483-8. PubMed ID: 25394955
    [Abstract] [Full Text] [Related]

  • 10. Endocan: A novel inflammatory indicator in cardiovascular disease?
    Balta S, Mikhailidis DP, Demirkol S, Ozturk C, Celik T, Iyisoy A.
    Atherosclerosis; 2015 Nov; 243(1):339-43. PubMed ID: 26448266
    [Abstract] [Full Text] [Related]

  • 11. Endocan--a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study.
    Balta S, Mikhailidis DP, Demirkol S, Ozturk C, Kurtoglu E, Demir M, Celik T, Turker T, Iyisoy A.
    Angiology; 2014 Oct; 65(9):773-7. PubMed ID: 24402320
    [Abstract] [Full Text] [Related]

  • 12. Early markers of cardiovascular risk in chronic kidney disease.
    Lai S, Dimko M, Galani A, Coppola B, Innico G, Frassetti N, Mazzei ED, Mariotti A.
    Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
    [Abstract] [Full Text] [Related]

  • 13. The Relationship between Vascular Biomarkers (Serum Endocan and Endothelin-1), NT-proBNP, and Renal Function in Chronic Kidney Disease, IgA Nephropathy: A Cross-Sectional Study.
    Sági B, Vas T, Gál C, Horváth-Szalai Z, Kőszegi T, Nagy J, Csiky B, Kovács TJ.
    Int J Mol Sci; 2024 Sep 30; 25(19):. PubMed ID: 39408883
    [Abstract] [Full Text] [Related]

  • 14. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients.
    Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU, Gok M, Caglar K, Oguz Y, Yenicesu M, Cetinkaya H, Eyileten T, Acikel C, Vural A, Covic A.
    Am J Nephrol; 2012 Sep 30; 36(3):228-37. PubMed ID: 22948239
    [Abstract] [Full Text] [Related]

  • 15. Serum Endocan Levels are Associated With Paraoxonase 1 Concentration in Patients With Chronic Kidney Disease.
    Samouilidou E, Bountou E, Papandroulaki F, Papamanolis M, Papakostas D, Grapsa E.
    Ther Apher Dial; 2018 Aug 30; 22(4):325-331. PubMed ID: 29368426
    [Abstract] [Full Text] [Related]

  • 16. Endocan Levels and Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus.
    Icli A, Cure E, Cure MC, Uslu AU, Balta S, Mikhailidis DP, Ozturk C, Arslan S, Sakız D, Sahin M, Kucuk A.
    Angiology; 2016 Sep 30; 67(8):749-55. PubMed ID: 26614790
    [Abstract] [Full Text] [Related]

  • 17. Endocan: a novel predictor of endothelial dysfunction in obstructive sleep apnea syndrome.
    Kanbay A, Ceylan E, Köseoğlu Hİ, Çalışkan M, Takir M, Tulu S, Telci Çaklılı O, Köstek O, Erek A, Afsar B.
    Clin Respir J; 2018 Jan 30; 12(1):84-90. PubMed ID: 27116287
    [Abstract] [Full Text] [Related]

  • 18. The Association Between Endocan Levels and Subclinical Atherosclerosis in Patients With Type 2 Diabetes Mellitus.
    Lv Y, Zhang Y, Shi W, Liu J, Li Y, Zhou Z, He Q, Wei S, Liu J, Quan J.
    Am J Med Sci; 2017 May 30; 353(5):433-438. PubMed ID: 28502328
    [Abstract] [Full Text] [Related]

  • 19. The relationship between IL-10 levels and cardiovascular events in patients with CKD.
    Yilmaz MI, Solak Y, Saglam M, Cayci T, Acikel C, Unal HU, Eyileten T, Oguz Y, Sari S, Carrero JJ, Stenvinkel P, Covic A, Kanbay M.
    Clin J Am Soc Nephrol; 2014 Jul 30; 9(7):1207-16. PubMed ID: 24789549
    [Abstract] [Full Text] [Related]

  • 20. Endocan as a potential diagnostic or prognostic biomarker for chronic kidney disease.
    Lee HG, Choi HY, Bae JS.
    Kidney Int; 2014 Dec 30; 86(6):1079-81. PubMed ID: 25427083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.